<DOC>
	<DOCNO>NCT00886262</DOCNO>
	<brief_summary>The purpose study evaluate medication vasopressin ability preserve kidney function patient undergo liver transplantation .</brief_summary>
	<brief_title>Study Evaluate Drug Vasopressin Protects Kidneys Patients Undergoing Liver Transplant</brief_title>
	<detailed_description>Renal failure common complication liver disease . Hepatorenal syndrome cause dysfunctional global circulation set liver disease : Increased flow mesenteric circulation contributor decrease blood flow kidney ( 1 ) . Renal failure often worsen perioperative period liver transplantation since kidney stress reduce flow due inferior venacava occlusion , decrease blood flow kidney anesthetic , well hypotension volume shift , large volume ascites remove . Renal failure cause major morbidity mortality patient undergo liver transplantation . Vasopressin logical choice therapy context effect drug work particularly increase renal blood flow glomerular filtration rate due location specific vasopressin receptor within renal vasculature . It suggest use splanchnic ( systemic ) vasoconstrictor terlipressin ( vasopressin analog ) alpha-1-adrenoceptor agonist ( midodrine noradrenaline ) may improve renal function patient type 1 Hepatorenal Syndrome . Six study ( one randomize study small series patient ) show terlipressin improves renal function patient ( 2-7 ) . This drug available Europe , United States . However , anesthesiologist commonly use vasopressin liver transplantation set hepatorenal syndrome vasodilatory shock , validity practice effect renal function outcomes rigorously study ( 8-10 ) . Therefore , purpose study evaluate effect low-dose vasopressin intraoperative perioperative renal function liver transplant patient . This study randomize , double-blind control trial performed adult liver transplant patient come surgery chronic liver disease ; major end-points analyse renal function test perioperative period .</detailed_description>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Vasopressins</mesh_term>
	<mesh_term>Arginine Vasopressin</mesh_term>
	<criteria>&gt; 18 year age undergo liver transplant ability provide inform consent . If patient unable give inform consent i.e . hepatic encephalopathy , consent may obtain patient 's legally authorize representative &lt; 18 year age renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>liver transplantation</keyword>
	<keyword>vasopressin</keyword>
	<keyword>renal function</keyword>
	<keyword>hypotension</keyword>
	<keyword>creatinine</keyword>
	<keyword>urine output</keyword>
	<keyword>diuretic</keyword>
	<keyword>vasopressor</keyword>
	<keyword>hemodynamic stability</keyword>
</DOC>